Dr. Clement is an Executive PV Consultant for the pharmaceutical industry. He has worked in Drug Safety and Pharmacovigilance in multiple capacities, mostly with global responsibilities. In his last role, he was leading the PV activities for Cubist (now part of Merck) as Vice-President, Global Pharmacovigilance & Medical Risk Management. In his previous roles, he was VP for Drug Safety and Pharmacovigilance at Onyx/Amgen, and prior to that assumed different leadership roles with Janssen, sanofi, Lipha-Merck Kga, Abbott and Janssen France. Dr. Clement graduated in Family Medicine from the Pierre and Marie Curie Medical University, Paris, France, and worked in clinical practice for 8 years before joining the pharmaceutical industry. He also studied Pharmacology at Faculties of Pierre & Marie Curie Paris 6, Lariboisiere Paris 5 and Claude Bernard Lyon, France.